Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
779K
-
Shares change
-
-16.3K
-
Total reported value, excl. options
-
$44.6M
-
Value change
-
-$936K
-
Number of buys
-
1
-
Number of sells
-
-7
-
Price
-
$57.25
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q4 2020
8 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q4 2020.
NOVOZYMES A S DKK 2.0 - COM has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 779K shares
.
Largest 8 shareholders include Hemenway Trust Co LLC (207K shares), SOMERVILLE KURT F (201K shares), Broderick Brian C (103K shares), PUZO MICHAEL J (87.6K shares), Kidder Stephen W (82.5K shares), Page Arthur B (37.1K shares), Notis-McConarty Edward (32.9K shares), and Dempze Nancy E (26.9K shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.